Olema Pharmaceuticals Net Debt Growth & History (OLMA)

Olema Pharmaceuticals's net debt was −$47.1M for fiscal 2025.

View full Olema Pharmaceuticals company overview

Olema Pharmaceuticals annual net debt history

Olema Pharmaceuticals annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$47.1M$90.9M
20242024-12-31−$138.1M−$71.9M
20232023-12-31−$66.1M−$45.0M
20222022-12-31−$21.1M−$10.6M
20212021-12-31−$10.5M

Olema Pharmaceuticals net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Olema Pharmaceuticals's net debt decreased from −$10.5M to −$47.1M, a change of −$36.6M. The latest reported quarter, Q2 2026, shows −$47.9M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Olema Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about OLMA yet. Start the conversation.

Write the first post